common.study.topics.clinical

Treatments for Open-Angle Glaucoma or Ocular Hypertension

common.study.values.description

Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

This study will evaluate the intraocular pressure-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Drug - Bimatoprost SR

Up to three Bimatoprost SR Dose A administrations at Day 4, Weeks 16 and 32 (Stage 1) or two Bimatoprost SR Dose B administrations at Day 4 and Week 16 (Stage 2).

Drug - Sham Bimatoprost SR

Up to three Sham Bimatoprost SR administrations at Day 4, Weeks 16 and 32 (Stage 1) or two Sham Bimatoprost SR administrations at Day 4 and Week 16 (Stage 2).

Procedure - Selective Laser Trabeculoplasty

Selective Laser Trabeculoplasty administered on Day 1.

Procedure - Sham Selective Laser Trabeculoplasty

Sham Selective Laser Trabeculoplasty administered on Day 1.

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

common.study.values.clinical-trial-id

NCT02507687

participant.views.study.view.id

QbY0Wa